A Centers for Medicare & Medicaid Services (CMS) proposal would cut providers' reimbursement for dialysis treatment by 9.4%, or approximately $1 billion, nationwide.
A Centers for Medicare & Medicaid Services (CMS) proposal would cut providers’ reimbursement for dialysis treatment by 9.4%, or approximately $1 billion, nationwide. Such changes alarm providers in the aftermath of other funding reductions that have affected Medicare, including the government sequestrian, and other mandates associated with health reform. The recommendations are part of adjustments to the end-stage renal disease (ESRD) program.
“This is a very dramatic cut," Robert Sepucha, Senior VP, Policy and Business Development at Fresenius Medical Care, said. “We’re concerned it would push dialysis clinics under the cost of care, which is not the right thing for Medicare to be doing.”
Recent estimates show that 85% of American dialysis patients rely on Medicare to receive kidney disease treatment. The CMS cuts would affect almost half a million Americans, threating the quality of care for some of the most sickly and vulnerable patients. An additional 20 million of those affected are at increased risk of ESRD due to health and genetic factors and may require dialysis in the future.
Heather Dauler, Director of Government Affairs at Satellite Healthcare, said communities rely on providers like the Satellite clinic to provide high quality care in an accessible way. “While we will continue to strive to meet these needs, the extent of the proposed cuts may compromise our ability to do so,” Ms Dauler commented.
Medicare had already faced difficulties in covering costs for many ESRD patients, even before the sequestrian effects.
"Dialysis providers are struggling to absorb and adjust to the other Medicare cuts made to the program in recent years," said Ron Kuerbitz, Chair of Kidney Care Partners. "The current proposal is untenable, and would dramatically underfund this crucial therapy for Medicare beneficiaries on dialysis. To protect the well-being of our patients, CMS must ensure that Medicare reimbursement is adequate to cover the cost of providing quality care.”
The CMS proposal remains open to public comment until August 30.
Around the Web
DaVita Among Dialysis Outlets Facing 9.4% Medicare Cut [Bloomberg]
Proposed Medicare Cuts Have Broad Implications For Dialysis Services Offerings [Herald Online]
Nation's Kidney Community Deeply Concerned Over Government's "Untenable" Proposed Cut to the Nation's Medicare's Dialysis Program
Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage
April 4th 2025This study examined postdiagnosis breast cancer treatment outcomes for Medicare Advantage vs fee-for-service (FFS) Medicare in Ohio and found no significant differences overall but disparities for Black patients with FFS Medicare.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
How Access to SMA Treatment Varies Globally and by Insurance Type
March 18th 2025Posters presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference show that therapeutic advances in treating spinal muscular atrophy (SMA) are not uniformly making it into the hands of patients who could benefit.
Read More